Status:
COMPLETED
Radiofrequency-assisted Liver Resection in Intractable Liver Cancer
Lead Sponsor:
Hepatopancreatobiliary Surgery Institute of Gansu Province
Conditions:
Liver Cancer
Eligibility:
All Genders
18-90 years
Brief Summary
In this retrospective study, the investigators assessed the application of radiofrequency-assisted liver resection in intractable liver cancer resection, and plan to analysis the different factors.
Detailed Description
The primary clinical treatment of liver cancer is surgical resection, although many integrated applications develop rapidly, surgery is still the best way to remove the tumour lesion. Traditional ways...
Eligibility Criteria
Inclusion
- Ultrasound-guided fine-needle aspiration pathology or postoperative pathology was confirmed to be liver cancer, no pathological results according to China 's 2017 version of the hepatocarcinoma (HCC) diagnosis and treatment specifications, in line with the standard clinical diagnosis of liver cancer
- According to Barcelona Clinic Liver Cancer (BCLC) staging criteria, it is stage C (stage C: single tumour\> 5 cm or more than three tumours, and at least one tumour\> 3 cm, liver function Child-Pugh A or B, with lymph node metastasis or distant metastasis or portal vein or Venous liver trunk is invaded, penance Status (PST) score 1-2 points)
Exclusion
- HCC patients with other malignant tumours
- Metastatic liver tumour
- Patients with liver abscess
- Patients with organ dysfunction
Key Trial Info
Start Date :
May 25 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 18 2021
Estimated Enrollment :
199 Patients enrolled
Trial Details
Trial ID
NCT04413526
Start Date
May 25 2020
End Date
November 18 2021
Last Update
November 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hepatopancreatobiliary Surgery Institute of Gansu Province
Lanzhou, Gansu, China, 730000